Evidence
Nihon Ronen Igakkai Zasshi. 2024;61(1):22. doi: 10.3143/geriatrics.61.22.
NO ABSTRACT
PMID:38583965 | DOI:10.3143/geriatrics.61.22
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Current status of blood-based biomarkers for dementia
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- The effect of marking and brightness adjustment on nocturnal toilet visits and repeated questions in person with dementia
- Actual conditions and factors related to the utilization of Twiddle Muff in removing mittens for patients with Dementia
- Vegetable-first eating habits are associated with a reduced risk of mild cognitive impairment in elderly diabetic patients
- Relationship between the type and number of social participation events and the cognitive function in older diabetics
- Decreased appetite is associated with a decreased cognitive function in elderly patients with diabetes
- Postnatal epigenome-mediated aging control and global trends
- A Multicenter randomized comparative study of dementia nursing practice skills development programs for nurses in acute care hospitals: A Comparison of person-centered care and dementia-type-specific programs
- New horizons in undergraduate geriatric medicine education
- Autonomic and hedonic response to affective touch in autism spectrum disorder
- Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey
- Topics in alcohol-associated/related liver disease
- Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach
- Correction to: Artificial Intelligence in Geriatrics: Riding the Inevitable Tide of Promise, Challenges, and Considerations
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Answer to the commentary on the paper "Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey"
- Effect of a Three-Component Geriatrics Bundle on Incident Delirium Among Critically Ill Older Adults: A Pilot Study
- Technological acceptance and features needed in mobile health apps development for people living with dementia and their caregivers in Indonesia
- Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study
- Molecular biomarkers for vascular cognitive impairment and dementia: the current status and directions for the future
- Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
- Predicting cognitive function and dementia risk in patients with hypertension
- Utility of Life Stage-Specific Chemical Risk Assessments Based on New Approach Methodologies (NAMs)
- The current status of apathy in patients with dementia and its factors: A systematic review
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Impact of inpatient geriatrics consultation on hospital outcomes in older adults with trauma
- What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
- Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
- The association of blood biomarkers with cerebral white matter and myelin content in bipolar disorder: a systematic review
- Validity assessment of self-reported medication use in a pharmacoepidemiologic study by comparison with prescription record review
- Validity assessment of self-reported medication use in a pharmacoepidemiologic study by comparison with prescription record review
- Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population
- Hospital and out-of-hospital services provided by public geriatric medicine departments in Australia and New Zealand
- Hospital and out-of-hospital services provided by public geriatric medicine departments in Australia and New Zealand
- Blood tests for diagnosing dementia a step closer
- AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
- A Nationwide Emergency Department Data Analysis to Predict Beers List Medications Use Among Older Adults
- Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient
- Validation of the de Morton mobility index (DEMMI) among acute stroke patients aged ≥65 years: a register study
- Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians
- Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort
- Terminally differentiated effector memory T cells associate with cognitive and AD-related biomarkers in an aging-based community cohort
- Forecasting the 20-Year Incidence of Dementia by Socioeconomic Status, Race/Ethnicity, and Region Based on Mid-Life Risk Factors in a U.S. Nationally Representative Sample
- Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease
- Uncovering predictors of low hippocampal volume: Evidence from a large-scale machine-learning-based study in the UK Biobank
- Associations between regional blood-brain barrier permeability, aging, and Alzheimer's disease biomarkers in cognitively normal older adults
- The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials
- Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer
- Pharmacological Treatment for Terminal Agitation, Delirium and Anxiety in Frail Older Patients
- Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease
- Physical frailty predicts cognitive decline among community-dwelling older Japanese women: A prospective cohort study from the Otassha study
- Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis
- A scoping review of functional near-infrared spectroscopy biomarkers in late-life depression: Depressive symptoms, cognitive functioning, and social functioning
- Proteomic studies in VWA1-related neuromyopathy allowed new pathophysiological insights and the definition of blood biomarkers
- Healthcare Awareness Profile Interview: Development of a new evidence-based brief clinical tool to assess awareness in people with dementia
- Cross-sectional associations between neighborhood characteristics, cognition and dementia risk factor burden in middle-aged and older Australians
- Phosphatidylethanol (B-PEth) and other direct and indirect biomarkers of alcohol consumption
- Novel biomarkers of preterm brain injury from blood transcriptome in sheep model of intrauterine asphyxia
- Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes
- Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies
- Subclinical vascular composites predict clinical cardiovascular disease, stroke, and dementia: The Multi-Ethnic Study of Atherosclerosis (MESA)
- Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Biochemical, Hematological, Inflammatory, and Gut Permeability Biomarkers in Patients with Alcohol Withdrawal Syndrome with and without Delirium Tremens
Evidence Blueprint
Current status of blood-based biomarkers for dementia
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Current status of blood-based biomarkers for dementia
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- The effect of marking and brightness adjustment on nocturnal toilet visits and repeated questions in person with dementia
- Actual conditions and factors related to the utilization of Twiddle Muff in removing mittens for patients with Dementia
- Vegetable-first eating habits are associated with a reduced risk of mild cognitive impairment in elderly diabetic patients
- Relationship between the type and number of social participation events and the cognitive function in older diabetics
- Decreased appetite is associated with a decreased cognitive function in elderly patients with diabetes
- Postnatal epigenome-mediated aging control and global trends
- A Multicenter randomized comparative study of dementia nursing practice skills development programs for nurses in acute care hospitals: A Comparison of person-centered care and dementia-type-specific programs
- New horizons in undergraduate geriatric medicine education
- Autonomic and hedonic response to affective touch in autism spectrum disorder
- Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
- Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey
- Topics in alcohol-associated/related liver disease
- Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease
- Integrative medicine and geriatrics : towards a convergence?
- Present and future of Blood-Based biomarkers of Alzheimer's Disease: Beyond the classics
- Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis
- Blood-based biomarkers in Alzheimer's disease - moving towards a new era of diagnostics
- Nutritional approach for chronic liver injury and treatment for alcoholic liver diseases
- Development and Evaluation of a Clinician-Vetted Dementia Caregiver Resources Website: Mixed Methods Approach
- Quality of life among geriatric population residing in Bhavnagar city, Gujarat, Western India
- Correction to: Artificial Intelligence in Geriatrics: Riding the Inevitable Tide of Promise, Challenges, and Considerations
- The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
- Answer to the commentary on the paper "Geriatrics and artificial intelligence in Spain (Ger-IA project): talking to ChatGPT, a nationwide survey"
- Effect of a Three-Component Geriatrics Bundle on Incident Delirium Among Critically Ill Older Adults: A Pilot Study
- Technological acceptance and features needed in mobile health apps development for people living with dementia and their caregivers in Indonesia
- Case report: a unique presentation of memantine overdose causing echolalia and hypertension
- Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study
- Molecular biomarkers for vascular cognitive impairment and dementia: the current status and directions for the future
- Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
- Predicting cognitive function and dementia risk in patients with hypertension
- Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology
- Utility of Life Stage-Specific Chemical Risk Assessments Based on New Approach Methodologies (NAMs)
- Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings
- Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging
- Empowering general practitioners in dementia care: The ANTISTIGMA education intervention in Europe
- Outcomes from an interprofessional, dementia-focused, telementoring program: a brief report
- DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers
- The current status of apathy in patients with dementia and its factors: A systematic review
- Association between Modifiable Risk Factors and Levels of Blood-Based Biomarkers of Alzheimer's and Related Dementias in the Look AHEAD Cohort
- Expressed Emotion in Families of People With Dementia: A Review of Scale-Based Measures
- Biomarkers associated with the pathogenesis of Alzheimer's disease
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review
- Mild Behavioral Impairment and Cerebrovascular Profiles Are Associated with Early Cognitive Impairment in a Community-Based Southeast Asian Cohort
- Microglial regulation of brain function and pathological changes
- Impact of inpatient geriatrics consultation on hospital outcomes in older adults with trauma
- What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
- Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
- The association of blood biomarkers with cerebral white matter and myelin content in bipolar disorder: a systematic review
- Validity assessment of self-reported medication use in a pharmacoepidemiologic study by comparison with prescription record review
- Validity assessment of self-reported medication use in a pharmacoepidemiologic study by comparison with prescription record review
- Effects of Vascular Risk Factors on the Association of Blood-Based Biomarkers with Alzheimer's Disease
- Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population
- Hospital and out-of-hospital services provided by public geriatric medicine departments in Australia and New Zealand
- Hospital and out-of-hospital services provided by public geriatric medicine departments in Australia and New Zealand
- Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology
- Blood tests for diagnosing dementia a step closer
- AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort
- A Nationwide Emergency Department Data Analysis to Predict Beers List Medications Use Among Older Adults
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Serum proinsulin levels as peripheral blood biomarkers in patients with cognitive impairment
- Relationship between mortality and vitality in patients with mild cognitive impairment/dementia: An 8-year retrospective study
Indementia